• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Marizyme Inc (OP:MRZM)

0.0003 UNCHANGED
Last Price Updated: 2:48 PM EDT, Apr 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0003
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0003
Today's Range 0.0003 - 0.0003
52wk Range 0.0003 - 0.0500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Marizyme, Inc. Secures FDA 510(k) Clearance for Controlled Room Temperature Storage DuraGraft
May 06, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Marizyme, Inc. Secures FDA 510(k) Clearance for Controlled Room Temperature Storage DuraGraft
May 06, 2024
JUPITER, FL - (NewMediaWire) - May 06, 2024 - Marizyme, Inc. (OTCQB: MRZM) is pleased to announce that its flagship product DuraGraft® will no longer require refrigerated storage and will be able to be... 
Via TheNewswire.com
Topics Economy

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
-99.4%
-99.4%

More News

Read More
News headline image
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft(TM)
April 16, 2024
Via NewMediaWire
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft(TM)
April 16, 2024
Via TheNewswire.com
News headline image
Marizyme CEO Delivers Business Update
October 23, 2023
Via NewMediaWire
News headline image
InvestmentPitch Media Video Features Marizyme's CEO David Barthel Discussing Receipt of FDA Clearance for its Flagship DuraGraft Medical Device
October 13, 2023
Via ACCESSWIRE
News headline image
The Watchlist by The Market Herald Releases New Interviews with Marizyme, Regenx, BuildDirect, and Three Sixty Solar Discussing Their Latest News
October 06, 2023
Via ACCESSWIRE
News headline image
Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft
October 06, 2023
Via NewMediaWire
News headline image
Marizyme (OTCQB: MRZM) Announces IP Developments for DuraGraft and Its Pipeline Products
May 10, 2023
Via Spotlight Growth
Topics Intellectual Property
News headline image
Marizyme Announces IP Developments for DuraGraft and Its Pipeline Products
May 10, 2023
Via NewMediaWire
Topics Intellectual Property
News headline image
Marizyme (OTCQB: MRZM) CEO Delivers Business Update
May 03, 2023
Via Spotlight Growth
News headline image
Marizyme CEO Delivers Business Update
May 03, 2023
Via NewMediaWire
News headline image
Marizyme Announces Allowance of Patent Application for Flagship Product DuraGraft by United States Patent and Trademark Office
January 05, 2022
Via NewMediaWire
Topics Intellectual Property
News headline image
Marizyme Announces the Closing of My Health Logic Acquisition Along With Initial Financing
December 23, 2021
Via NewMediaWire
News headline image
Marizyme Inc. Announces Results of GOAL Study Presented at 7th Annual International Coronary Congress
December 03, 2021
Via NewMediaWire
News headline image
Marizyme Announces Expansion of Patent Portfolio Into Several Key Territories
December 03, 2021
Via NewMediaWire
Topics Intellectual Property
News headline image
Marizyme is Pleased to Announce the Appointment of David Barthel as CEO
November 16, 2021
Via NewMediaWire
Topics Intellectual Property

Frequently Asked Questions

Is Marizyme Inc publicly traded?
Yes, Marizyme Inc is publicly traded.
What exchange does Marizyme Inc trade on?
Marizyme Inc trades on the OTC Traded
What is the ticker symbol for Marizyme Inc?
The ticker symbol for Marizyme Inc is MRZM on the OTC Traded
What is the current price of Marizyme Inc?
The current price of Marizyme Inc is 0.0003
When was Marizyme Inc last traded?
The last trade of Marizyme Inc was at 04/14/25 02:48 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap